Streetbeat News

Revenues

ASMB

BKYI

EVLO

NTCT

OLK

SPRC

US stocks traded lower with the Nasdaq Composite falling more than 1%. U.S. retail sales rose 0.7% month-over-month in September, beating estimates of a 0.3% increase. Energy shares climbed by 0.6% while information technology shares fell by 2.1%. SciSparc Ltd., Assembly Biosciences, Inc., and Olink Holding AB saw their shares rise significantly. Evelo Biosciences, Inc., NetScout Systems, Inc., and BIO-key International, Inc. saw their shares drop.

Portfolio Pulse from Lisa Levin

October 17, 2023 | 2:01 pm

MRNA

PFE

Moderna Inc's shares continue to trade lower following Pfizer Inc's warning about reduced Covid-19 product demand. Pfizer slashed its full-year 2023 sales outlook from $67 billion-$70 billion to $58 billion-$61 billion, causing shares of several Covid vaccine makers, including Moderna, to slide. Despite this, Moderna reaffirmed its $6 billion-$8 billion forecast for Covid vaccine sales for the year.

Portfolio Pulse from Adam Eckert

October 17, 2023 | 1:52 pm

BAC

Bank of America's CFO has stated that the bank has a strong investment banking pipeline. This suggests that the bank is expecting a steady flow of deals and transactions, which could potentially boost its revenues and profitability.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 1:49 pm

EPOW

Sunrise New Energy Co., Ltd. (NASDAQ:EPOW) has announced the successful delivery of over 3,000 tons of products to Narada Power from January to September 2023. The company has become a strategic supplier for Narada Power since April 2022 and expects to reach an annual supply of 5,000 tons in 2023 and 8,000 tons in 2024. This partnership has resulted in predictable and sustained revenue growth for Sunrise.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 1:27 pm

RVSN

Rail Vision has received a $500,000 order from a Latin America mining company. The company's stock, RVSN, may be impacted by this news.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 1:01 pm

SPY

The USA Redbook Year-over-Year (YoY) has reported a 4.6% increase, compared to the previous 4.0%.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 12:55 pm

SYLA

SYLA Technologies reported its first-half 2023 financial results, showing an increase in revenue to $64.5M from $56.1M YoY, and an EPS of $(5.77) compared to $(2.50) YoY. The revenue increase was attributed to an increase in land sales and data center container sales. However, this was offset by a decrease in real estate sales. Gross profit and total operating expenses also increased. Net income attributable to SYLA was $1.7M, compared to $0.7M YoY. As of June 30, 2023, SYLA had $24.7M in cash and cash equivalents.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 12:39 pm

NRSN

Neurosense Therapeutics Ltd is set to enroll its first patient in a Phase 2 Alzheimer's Disease study in the coming weeks. The company is fully funded into Q2 2024 and expects results from its Clinical Phase 2b ALS study in Q4 2023.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 12:35 pm

SPY

The USA Retail Control for September has been reported at 0.6%, significantly higher than the estimated 0.1% and the prior figure of 0.2%.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 12:31 pm

SPY

USA Core Retail Sales for September increased by 0.6%, beating the estimated 0.2% and higher than the prior 0.9%.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 12:30 pm